Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases

por Higashiyama, Nicole, Nangia, Julie, Shafaee, Maryam Nemati, Chen, Nan, Michael, Binu Liz, Rimawi, Mothaffar, Hoyos, Valentina
Publicado 2020

Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

por Hoyos, Valentina, Vasileiou, Spyridoula, Kuvalekar, Manik, Watanabe, Ayumi, Tzannou, Ifigeneia, Velazquez, Yovana, French-Kim, Matthew, Leung, Wingchi, Lulla, Suhasini, Robertson, Catherine, Foreman, Claudette, Wang, Tao, Bulsara, Shaun, Lapteva, Natalia, Grilley, Bambi, Ellis, Matthew, Osborne, Charles Kent, Coscio, Angela, Nangia, Julie, Heslop, Helen E., Rooney, Cliona M., Vera, Juan F., Lulla, Premal, Rimawi, Mothaffar, Leen, Ann M.
Publicado 2022

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

por Freedman, Rachel A., Gelman, Rebecca S., Anders, Carey K., Melisko, Michelle E., Parsons, Heather A., Cropp, Anne M., Silvestri, Kelly, Cotter, Christine M., Componeschi, Kathryn P., Marte, Juan M., Connolly, Roisin M., Moy, Beverly, Van Poznak, Catherine H., Blackwell, Kimberly L., Puhalla, Shannon L., Jankowitz, Rachel C., Smith, Karen L., Ibrahim, Nuhad, Moynihan, Timothy J., O’Sullivan, Ciara C., Nangia, Julie, Niravath, Polly, Tung, Nadine, Pohlmann, Paula R., Burns, Robyn, Rimawi, Mothaffar F., Krop, Ian E., Wolff, Antonio C., Winer, Eric P., Lin, Nancy U.
Publicado 2019

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

por Anurag, Meenakshi, Jaehnig, Eric J., Krug, Karsten, Lei, Jonathan T., Bergstrom, Erik J., Kim, Beom-Jun, Vashist, Tanmayi D., Huynh, Anh Minh Tran, Dou, Yongchao, Gou, Xuxu, Huang, Chen, Shi, Zhiao, Wen, Bo, Korchina, Viktoriya, Gibbs, Richard A., Muzny, Donna M., Doddapaneni, Harshavardhan, Dobrolecki, Lacey E., Rodriguez, Henry, Robles, Ana I., Hiltke, Tara, Lewis, Michael T., Nangia, Julie R., Nemati Shafaee, Maryam, Li, Shunqiang, Hagemann, Ian S., Hoog, Jeremy, Lim, Bora, Osborne, C. Kent, Mani, D.R., Gillette, Michael A., Zhang, Bing, Echeverria, Gloria V., Miles, George, Rimawi, Mothaffar F., Carr, Steven A., Ademuyiwa, Foluso O., Satpathy, Shankha, Ellis, Matthew J.
Publicado 2022

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts

por Strand, Siri H., Rivero-Gutiérrez, Belén, Houlahan, Kathleen E., Seoane, Jose A., King, Lorraine M., Risom, Tyler, Simpson, Lunden A., Vennam, Sujay, Khan, Aziz, Cisneros, Luis, Hardman, Timothy, Harmon, Bryan, Couch, Fergus, Gallagher, Kristalyn, Kilgore, Mark, We, Shi, DeMichele, Angela, King, Tari, McAuliffe, Priscilla F., Nangia, Julie, Lee, Joanna, Tseng, Jennifer, Storniolo, Anna Maria, Thompson, Alastair M., Gupta, Gaorav P., Burns, Robyn, Veis, Deborah J., DeSchryver, Katherine, Zhu, Chunfang, Matusiak, Magdalena, Wang, Jason, Zhu, Shirley X., Tappenden, Jen, Ding, Daisy Yi, Zhang, Dadong, Luo, Jingqin, Jiang, Shu, Varma, Sushama, Anderson, Lauren, Straub, Cody, Srivastava, Sucheta, Curtis, Christina, Tibshirani, Rob, Angelo, Robert Michael, Hall, Allison, Owzar, Kouros, Polyak, Kornelia, Maley, Carlo, Marks, Jeffrey R., Colditz, Graham A., Shelley Hwang, E., West, Robert B.
Publicado 2023